Your session is about to expire
← Back to Search
Behavioural Intervention
Self-Distancing for Pediatric Anxiety and OCD
N/A
Waitlist Available
Led By Kate D Fitzgerald, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline (~1 week before treatment session) and at one month post-treatment.
Awards & highlights
No Placebo-Only Group
Summary
This trial is looking at a technique called Self-Distancing, which involves changing your perspective to a more objective view in emotionally charged situations. The study wants to see if using self-distancing can help
Who is the study for?
This trial is for children with anxiety disorders, OCD, or compulsive personality disorder. It's designed to see if a new way of thinking called self-distancing can help them better handle situations that scare them compared to classic exposure therapy.
What is being tested?
The study compares two methods: Self-Distancing (EXSD), where kids learn to shift their perspective in scary situations, and Classic Exposure (EXC), the usual way of facing fears directly. Researchers will measure how these techniques affect the children's willingness to face fears and their anxiety levels.
What are the potential side effects?
Since both interventions are psychological strategies rather than medications, they may not have typical 'side effects'. However, participating children might experience increased anxiety or distress temporarily when facing feared situations during therapy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at baseline (during phone screening), immediately after the one-session treatment and one month post-treatment.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline (during phone screening), immediately after the one-session treatment and one month post-treatment.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
APA Severity Measure for Specific Phobia-Child Age 11-17
Spider Phobia Questionnaire (SPQ)
Secondary study objectives
Behavioral Approach Test
Treatment Engagement and Adherence Ratings (TEARS)
Other study objectives
Electrodermal activity
Heart rate and Heart Rate Variability
Screen for Child Anxiety Related Disorders (SCARED)- Parent and Child
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Self-DistancingExperimental Treatment1 Intervention
Youth will be randomized to OST exposure therapy with Self-Distancing. In this arm, participants will be instructed to describe exposure tasks from a self-distanced perspective (e.g., "Emily is going to touch the spider").
Group II: Classic ExposureActive Control1 Intervention
Youth will be randomized to OST using classic exposure. In this arm, participants will be instructed to describe exposure tasks from a self-immersed perspective (e.g.,"I'm going to touch the spider")
Find a Location
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,495 Previous Clinical Trials
2,763,971 Total Patients Enrolled
Kate D Fitzgerald, MDPrincipal InvestigatorProfessor of Psychiatry
1 Previous Clinical Trials
48 Total Patients Enrolled